Socket Augmentation Using Atorvastatin With Or Without PRGF (Clinical and Histomorphometric Study)
Status:
Completed
Trial end date:
2018-08-15
Target enrollment:
Participant gender:
Summary
Despite the numerous studies describing the benefits of PRGF (plasma rich in growth factors)
and Statins separately , there has been a lack of clinical investigation into the
simultaneous use of these agents in socket augmentation. Therefore the main objective of this
study is to evaluate socket bone dimensions and quality following the use of PRGF derived
fibrin scaffold as a carrier for Atorvastatin in socket augmentation clinically and
histomorphometrically.